CONDENSED STATEMENT OF CASH FLOWS
|
9 Months Ended |
|
Sep. 30, 2020
USD ($)
|
|---|
| Cash Flows from Operating Activities: |
|
| Net loss |
$ (2,349,569)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
| Interest earned on cash and marketable securities held in Trust Account |
(96,607)
|
| Changes in operating assets and liabilities: |
|
| Prepaid expenses |
(465,382)
|
| Accrued expenses |
1,807,280
|
| Net cash used in operating activities |
(1,104,278)
|
| Cash Flows from Investing Activities: |
|
| Investment of cash in Trust Account |
(828,000,000)
|
| Net cash used in investing activities |
(828,000,000)
|
| Cash Flows from Financing Activities: |
|
| Proceeds from issuance of Class B ordinary shares to Sponsor |
25,000
|
| Proceeds from sale of Units, net of underwriting discounts paid |
813,600,000
|
| Proceeds from sale of Private Placement Warrants |
16,400,000
|
| Repayment of advances from related parties |
(17,631)
|
| Proceeds from promissory note - related party |
300,000
|
| Repayment of promissory note - related party |
(300,000)
|
| Payment of offering costs |
(776,346)
|
| Net cash provided by financing activities |
829,231,023
|
| Net Change in Cash |
126,745
|
| Cash - Beginning |
0
|
| Cash - Ending |
126,745
|
| Non-cash investing and financing activities: |
|
| Initial classification of ordinary shares subject to possible redemption |
795,251,020
|
| Change in value of ordinary shares subject to possible redemption |
(2,349,569)
|
| Deferred underwriting fee |
$ 28,980,000
|